2616 (2616) News
Follow 2616 (2616) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
CStone Pharmaceuticals HKEX:2616
EQUITY | Sep 24, 2026, 02:12 PM UTC
L
Shan Loong Transportation August revenue rises to NT$785.3M
Shan Loong Transportation reported August revenue of NT$785,252,000, versus NT$707,434,000 in 2025. For Jan-Aug, revenue was NT$5,950,277,000 versus NT$5,379,543,000 in 2025, according to the Taiwan Stock Exchange.
EQUITY | Sep 10, 2026, 07:15 AM UTC
M
Unresolved CStone posts 2026 interim results
CStone reported 2026 interim results, citing accelerating Pipeline 2.0 execution and sustained global commercial momentum.
EQUITY | Aug 27, 2026, 02:16 PM UTC
L
China's CStone Pharmaceuticals H1 revenue soars on drug sales
China's CStone Pharmaceuticals H1 revenue soars on drug sales
GEOPOLITICS | Aug 27, 2026, 11:40 AM UTC